Effect of Losartan on echocardiographic Left heart morphology,function in patients with congestive heart failure
Yang Cheng-di
Abstract
Yang Cheng-di
Abstract
Objectives To assess effects of Losartan on echocatrdiographic left heart morphology,function in patientswith congestive heart failure(CHF).Methods 36 patients with CHF treated with oral Losartan(50mg daily)for 2~4 weeks on base of usually treated,examined by eohocaridiography.Results The results showed that Left ventricular diameter(LVD) were significantly changed(P0.01),Letf heart function parameters were also increased significantly(P0.01).Conclusions These results showed that Losartan in the treatment of patient with CHF is benefical on acute hamemodynamic and decreased Left ventricult diameter.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objectives To assess effects of Losartan on echocatrdiographic left heart morphology,function in patientswith congestive heart failure(CHF).Methods 36 patients with CHF treated with oral Losartan(50mg daily)for 2~4 weeks on base of usually treated,examined by eohocaridiography.Results The results showed that Left ventricular diameter(LVD) were significantly changed(P0.01),Letf heart function parameters were also increased significantly(P0.01).Conclusions These results showed that Losartan in the treatment of patient with CHF is benefical on acute hamemodynamic and decreased Left ventricult diameter.
Key concepts: Losartan, Medicine, Heart failure, Cardiology, Internal medicine, Angiotensin II, Blood pressure